Masaki Nakamura, MD, is a radiation oncologist in the Department of Radiation Oncology at the National Cancer Center Hospital East in Japan. His clinical and research interests focus on the integration of advanced radiotherapy modalities—such as stereotactic body radiation therapy (SBRT) and particle beam therapy—with precision oncology. He is particularly focused on the clinical application of predictive biomarkers, including circulating tumor DNA (ctDNA) for molecular residual disease (MRD) detection, to personalize treatment strategies. Dr. Nakamura is an active investigator in several prospective multicenter clinical trials and research registries, including the MONSTAR project and the Japan Clinical Oncology Group (JCOG) studies.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none